Yonghui Zhao
Research Subjects
Yonghui Zhao has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Rajan Sah
Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA
4 shared publications - John D. Tranter
Department of Internal Medicine, Cardiovascular Division (Q.Y., Y.Z., J.M., P.A., N.J., J.D.T., T.M.A.E.-A., M.R., R.S.), Washington University School of Medicine, Saint Louis, MO
3 shared publications - Litao Xie
Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
3 shared publications - Ashutosh Kumar
Washington University
2 shared publications - Nihil Abraham
Department of Internal Medicine, Cardiovascular Division, Washington University School of Medicine, St. Louis, MO, USA
2 shared publications - Prakash Arullampalam
Department of Internal Medicine, Cardiovascular Division (Q.Y., Y.Z., J.M., P.A., N.J., J.D.T., T.M.A.E.-A., M.R., R.S.), Washington University School of Medicine, Saint Louis, MO
2 shared publications
Latest Publications
- 1 April 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (4) , e25889
Endothelial LRRC8C Associates With LRRC8A and LRRC8B to Regulate Vascular Reactivity and Blood Pressure
BACKGROUND: Endothelial mechanosensing is essential for controlling vascular tone. LRRC8A (leucine-rich repeat-containing protein 8A) was previously identified as a core subunit of the mechanoresponsive LRRC8 complex, functionally encoding the endothelial volume regulatory anion channel and regulating vascular function. This study aims to identify the molecular identity of the endothelial LRRC8 complex and its function in vascular reactivity and blood pressure control. METHODS: We generated germline epitope-tagged Lrrc8a -3xFlag knock-in mice and endothelium-specific Lrrc8a -3xFlag overexpression mice to permit LRRC8A and LRRC8C immunoprecipitation and define LRRC8 subunit interactions. We combined in vivo and in vitro loss-of-function models, electrophysiology, immunoblotting, and pressure myography of third-order mesenteric arteries to examine the contributions of individual LRRC8A/B/C subunits to vascular function and underlying signaling pathways. The contributions of LRRC8C to blood pressure control in vivo were further assessed using the angiotensin-induced hypertension model in Lrrc8c knockout mice. RESULTS: Although all LRRC8A-E subunits are expressed in endothelium, co-immunoprecipitation revealed enrichment of LRRC8A/B/C, suggesting the existence of an endothelial LRRC8A/B/C heteromer. Lrrc8a/b/c depletion studies showed codependent expression of LRRC8A/B/C, but not LRRC8D. Only LRRC8A and LRRC8C deficiency impaired AKT and endothelial NO synthase phosphorylation, increased myogenic tone (2.2- and 1.9-fold increase, respectively), and reduced endothelial NO synthase–dependent vasodilation (45% and 61% reduction, respectively). Global Lrrc8c knockout mice phenocopied Lrrc8a knockouts and exhibited exacerbated angiotensin-induced hypertension, as evidenced by 15% increase in mean arterial pressure. CONCLUSIONS: LRRC8A/B/C form the endothelial LRRC8 heteromeric complex. LRRC8C is nonredundant in supporting endothelial AKT-endothelial NO synthase signaling, vascular relaxation, and resistance to hypertension.
- 1 April 2026
- Published by Wolters Kluwer Health in Hypertension
- Vol. 83 (4) , e25889
Endothelial LRRC8C Associates With LRRC8A and LRRC8B to Regulate Vascular Reactivity and Blood Pressure
BACKGROUND: Endothelial mechanosensing is essential for controlling vascular tone. LRRC8A (leucine-rich repeat-containing protein 8A) was previously identified as a core subunit of the mechanoresponsive LRRC8 complex, functionally encoding the endothelial volume regulatory anion channel and regulating vascular function. This study aims to identify the molecular identity of the endothelial LRRC8 complex and its function in vascular reactivity and blood pressure control. METHODS: We generated germline epitope-tagged Lrrc8a -3xFlag knock-in mice and endothelium-specific Lrrc8a -3xFlag overexpression mice to permit LRRC8A and LRRC8C immunoprecipitation and define LRRC8 subunit interactions. We combined in vivo and in vitro loss-of-function models, electrophysiology, immunoblotting, and pressure myography of third-order mesenteric arteries to examine the contributions of individual LRRC8A/B/C subunits to vascular function and underlying signaling pathways. The contributions of LRRC8C to blood pressure control in vivo were further assessed using the angiotensin-induced hypertension model in Lrrc8c knockout mice. RESULTS: Although all LRRC8A-E subunits are expressed in endothelium, co-immunoprecipitation revealed enrichment of LRRC8A/B/C, suggesting the existence of an endothelial LRRC8A/B/C heteromer. Lrrc8a/b/c depletion studies showed codependent expression of LRRC8A/B/C, but not LRRC8D. Only LRRC8A and LRRC8C deficiency impaired AKT and endothelial NO synthase phosphorylation, increased myogenic tone (2.2- and 1.9-fold increase, respectively), and reduced endothelial NO synthase–dependent vasodilation (45% and 61% reduction, respectively). Global Lrrc8c knockout mice phenocopied Lrrc8a knockouts and exhibited exacerbated angiotensin-induced hypertension, as evidenced by 15% increase in mean arterial pressure. CONCLUSIONS: LRRC8A/B/C form the endothelial LRRC8 heteromeric complex. LRRC8C is nonredundant in supporting endothelial AKT-endothelial NO synthase signaling, vascular relaxation, and resistance to hypertension.
- Open Access
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadt6366
Lysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism
The lysosome integrates anabolic signaling and nutrient sensing to regulate intracellular growth pathways. The leucine-rich repeat–containing 8 (LRRC8) channel complex forms a lysosomal anion channel and regulates PI3K-AKT-mTOR signaling, skeletal muscle differentiation, growth, and systemic glucose metabolism. Here, we define the endogenous LRRC8 subunits localized to a subset of lysosomes in differentiated myotubes. We show that LRRC8A affects leucine-stimulated mTOR; lysosome size; number; pH; expression of lysosomal proteins LAMP2, P62, and LC3B; and lysosomal function. Mutating an LRRC8A lysosomal targeting dileucine motif sequence (LRRC8A-L706A;L707A) in myotubes recapitulates the abnormal AKT signaling and altered lysosomal morphology and pH observed in LRRC8A knockout cells. In vivo, LRRC8A-L706A;L707A knock-in mice exhibit increased adiposity, impaired glucose tolerance and insulin resistance associated with reduced skeletal muscle PI3K-AKT-mTOR signaling, glucose uptake, and impaired incorporation of glucose into glycogen. These data reveal a lysosomal LRRC8-mediated metabolic signaling function regulating lysosomal function, systemic glucose homeostasis, and insulin sensitivity.
- 26 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (39) , eadt6366
Open AccessLysosomal LRRC8 complex impacts lysosomal pH, morphology, and systemic glucose metabolism
The lysosome integrates anabolic signaling and nutrient sensing to regulate intracellular growth pathways. The leucine-rich repeat–containing 8 (LRRC8) channel complex forms a lysosomal anion channel and regulates PI3K-AKT-mTOR signaling, skeletal muscle differentiation, growth, and systemic glucose metabolism. Here, we define the endogenous LRRC8 subunits localized to a subset of lysosomes in differentiated myotubes. We show that LRRC8A affects leucine-stimulated mTOR; lysosome size; number; pH; expression of lysosomal proteins LAMP2, P62, and LC3B; and lysosomal function. Mutating an LRRC8A lysosomal targeting dileucine motif sequence (LRRC8A-L706A;L707A) in myotubes recapitulates the abnormal AKT signaling and altered lysosomal morphology and pH observed in LRRC8A knockout cells. In vivo, LRRC8A-L706A;L707A knock-in mice exhibit increased adiposity, impaired glucose tolerance and insulin resistance associated with reduced skeletal muscle PI3K-AKT-mTOR signaling, glucose uptake, and impaired incorporation of glucose into glycogen. These data reveal a lysosomal LRRC8-mediated metabolic signaling function regulating lysosomal function, systemic glucose homeostasis, and insulin sensitivity.
- Open Access
- 29 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (35) , eadw0424
Excitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels
Neuronal death in stroke and other conditions stems in part from stimulation of N -methyl- d -aspartate (NMDA)–type glutamate receptors. This induces neuronal production of both nitric oxide and superoxide, which together induce oxidative cell injury. Nitric oxide can readily cross lipid membranes, but superoxide, being an anion, cannot. Using primary neuronal cultures, we show that superoxide enters neurons through volume-regulated anion channels (VRACs). Oxidative injury produced by either exogenous superoxide or NMDA receptor stimulation is prevented by the VRAC inhibitor [4-(2-butyl-6,7-dichlor-2-cyclopentylindan-1-on-5-yl)oxybutyric acid] (DCPIB) and by disruption of the essential VRAC subunit, leucine-rich repeat–containing 8A (LRRC8A). In mouse cortex, neuronal oxidative injury induced by either NMDA or transient ischemia is likewise blocked by both DCPIB and LRRC8A disruption. Selective expression of LRRC8A/C and LRRC8A/E but not LRRC8A/D subunits conferred superoxide conductance in HeLa cells. Superoxide entry through VRACs is thus a requisite step in excitotoxic neuronal injury, and interventions affecting VRAC subunit composition, localization, or opening could influence neuronal survival.
- 29 August 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (35) , eadw0424
Open AccessExcitotoxic neuronal death requires superoxide entry into neurons through volume-regulated anion channels
Neuronal death in stroke and other conditions stems in part from stimulation of N -methyl- d -aspartate (NMDA)–type glutamate receptors. This induces neuronal production of both nitric oxide and superoxide, which together induce oxidative cell injury. Nitric oxide can readily cross lipid membranes, but superoxide, being an anion, cannot. Using primary neuronal cultures, we show that superoxide enters neurons through volume-regulated anion channels (VRACs). Oxidative injury produced by either exogenous superoxide or NMDA receptor stimulation is prevented by the VRAC inhibitor [4-(2-butyl-6,7-dichlor-2-cyclopentylindan-1-on-5-yl)oxybutyric acid] (DCPIB) and by disruption of the essential VRAC subunit, leucine-rich repeat–containing 8A (LRRC8A). In mouse cortex, neuronal oxidative injury induced by either NMDA or transient ischemia is likewise blocked by both DCPIB and LRRC8A disruption. Selective expression of LRRC8A/C and LRRC8A/E but not LRRC8A/D subunits conferred superoxide conductance in HeLa cells. Superoxide entry through VRACs is thus a requisite step in excitotoxic neuronal injury, and interventions affecting VRAC subunit composition, localization, or opening could influence neuronal survival.
- Open Access
- 28 August 2025
- Published by American Society of Hematology in Blood
- Vol. 146 (9) , 1110-1126
LRRC8 complexes are ATP release channels that regulate platelet activation and arterial thrombosis
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in leucine-rich repeat–containing 8 (LRRC8) protein subunits that form the volume-regulated anion channel (VRAC), which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume; adhesion; and agonist-stimulated activation, aggregation, adenosine triphosphate (ATP) secretion, and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser injury–induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without prolonged bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium–phosphoinositide 3-kinase–protein kinase B signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets, which positively regulates platelet function and thrombosis, providing a proof of concept for a novel antithrombotic drug target.
- 28 August 2025
- Published by American Society of Hematology in Blood
- Vol. 146 (9) , 1110-1126
Open AccessLRRC8 complexes are ATP release channels that regulate platelet activation and arterial thrombosis
Platelet shape and volume changes are early mechanical events contributing to platelet activation and thrombosis. Here, we identify single-nucleotide polymorphisms in leucine-rich repeat–containing 8 (LRRC8) protein subunits that form the volume-regulated anion channel (VRAC), which are independently associated with altered mean platelet volume. LRRC8A is required for functional VRAC in megakaryocytes (MKs) and regulates platelet volume; adhesion; and agonist-stimulated activation, aggregation, adenosine triphosphate (ATP) secretion, and calcium mobilization. MK-specific LRRC8A conditional knockout mice have reduced laser injury–induced cremaster arteriolar thrombus formation and prolonged FeCl3 induced carotid arterial thrombosis without prolonged bleeding times. Mechanistically, platelet LRRC8A mediates swell-induced cytosolic ATP release to amplify agonist-stimulated calcium–phosphoinositide 3-kinase–protein kinase B signaling. Small-molecule LRRC8 channel inhibitors recapitulate defects observed in LRRC8A-null platelets in vitro and in vivo. These studies identify the mechanoresponsive LRRC8 channel complex as an ATP release channel in platelets, which positively regulates platelet function and thrombosis, providing a proof of concept for a novel antithrombotic drug target.
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , 2499-2508.e3
Mechanisms of Broad-Band UVB Irradiation‒Induced Itch in Mice
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , 2499-2508.e3
Mechanisms of Broad-Band UVB Irradiation‒Induced Itch in Mice